| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.400 | None | 0.911 | 146 | 4 | 1986 | 2020 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.400 | None | 0.967 | 120 | 5 | 1990 | 2018 | ||||||||
|
prolactin | 0.406 | 0.885 | 2.9E-07 |
|
group | 0.400 | None | 0.981 | 107 | 0 | 1981 | 2019 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.959 | 97 | 2 | 1996 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.400 | None | 0.944 | 90 | 2 | 1991 | 2020 | ||||||||
|
potassium inwardly rectifying channel subfamily J member 5 | 0.560 | 0.577 | 3.4E-04 |
|
group | 0.400 | None | 1.000 | 34 | 2 | 2012 | 2019 | ||||||||
|
thyroid stimulating hormone receptor | 0.486 | 0.808 | 3.0E-15 |
|
group | 0.400 | None | 0.926 | 27 | 1 | 1993 | 2013 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.400 | None | 0.950 | 20 | 0 | 1994 | 2011 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
group | 0.400 | None | 0.875 | 16 | 0 | 1992 | 2019 | ||||||||
|
aryl hydrocarbon receptor interacting protein | 0.517 | 0.769 | 0.36 |
|
group | 0.400 | None | 1.000 | 15 | 2 | 2007 | 2019 | ||||||||
|
mucin 2, oligomeric mucus/gel-forming | 0.486 | 0.808 | 9.4E-10 |
|
group | 0.380 | None | 1.000 | 9 | 0 | 1994 | 2017 | ||||||||
|
alpha-methylacyl-CoA racemase | 0.510 | 0.769 | 2.7E-02 |
|
group | 0.360 | None | 1.000 | 6 | 1 | 1998 | 2007 | ||||||||
|
von Hippel-Lindau tumor suppressor | 0.443 | 0.846 | 8.0E-02 |
|
group | 0.350 | None | 1.000 | 6 | 0 | 1996 | 2005 | ||||||||
|
calcium voltage-gated channel subunit alpha1 D | 0.582 | 0.577 | 1.00 |
|
group | 0.350 | None | 1.000 | 6 | 1 | 2013 | 2017 | ||||||||
|
ATPase Na+/K+ transporting subunit alpha 1 | 0.601 | 0.808 | 1.00 |
|
group | 0.340 | None | 1.000 | 5 | 0 | 2013 | 2017 | ||||||||
|
selenoprotein P | 0.545 | 0.769 | 8.3E-07 |
|
group | 0.330 | None | 1.000 | 3 | 0 | 2000 | 2008 | ||||||||
|
arachidonate 5-lipoxygenase | 0.447 | 0.885 | 1.2E-06 |
|
group | 0.320 | None | 1.000 | 3 | 0 | 2007 | 2019 | ||||||||
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 | 0.617 | 0.577 | 2.2E-09 |
|
group | 0.320 | None | 1.000 | 3 | 0 | 2005 | 2014 | ||||||||
|
cytochrome P450 family 1 subfamily B member 1 | 0.457 | 0.769 | 2.2E-05 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 2001 | 2007 | ||||||||
|
BCL2 like 1 | 0.493 | 0.885 | 0.94 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 1999 | 2015 | ||||||||
|
solute carrier family 19 member 1 | 0.523 | 0.692 | 6.5E-06 |
|
group | 0.310 | None | 1.000 | 2 | 3 | 2007 | 2011 | ||||||||
|
ATPase plasma membrane Ca2+ transporting 3 | 0.631 | 0.692 | 1.00 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
transient receptor potential cation channel subfamily M member 7 | 0.531 | 0.731 | 5.2E-16 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
thioredoxin reductase 1 | 0.529 | 0.692 | 1.6E-06 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
SUZ12 polycomb repressive complex 2 subunit | 0.529 | 0.577 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 |